[HTML][HTML] Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B. 1.351) among persons identified through contact tracing in Israel …
SR Singer, FJ Angulo, DL Swerdlow… - …, 2021 - thelancet.com
Abstract Background SARS-CoV-2 variant Beta (B. 1.351) was designated as a Variant of
Concern (VoC) after becoming the dominant strain in South Africa and spreading …
Concern (VoC) after becoming the dominant strain in South Africa and spreading …
[HTML][HTML] Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B. 1.351) among persons identified through contact tracing in Israel …
SR Singer, FJ Angulo, DL Swerdlow, JM McLaughlin… - eClinicalMedicine, 2021 - Elsevier
Abstract Background SARS-CoV-2 variant Beta (B. 1.351) was designated as a Variant of
Concern (VoC) after becoming the dominant strain in South Africa and spreading …
Concern (VoC) after becoming the dominant strain in South Africa and spreading …
[HTML][HTML] Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B. 1.351) among persons identified through contact tracing in Israel …
SR Singer, FJ Angulo, DL Swerdlow… - …, 2021 - ncbi.nlm.nih.gov
Background SARS-CoV-2 variant Beta (B. 1.351) was designated as a Variant of Concern
(VoC) after becoming the dominant strain in South Africa and spreading internationally …
(VoC) after becoming the dominant strain in South Africa and spreading internationally …
Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B. 1.351) Among Persons Identified Through Contact Tracing in Israel
SR Singer, FJ Angulo, DL Swerdlow, JM McLaughlin… - papers.ssrn.com
Background: SARS-CoV-2 variant Beta (B. 1.351) was designated as a Variant of Concern
(VoC) after becoming the dominant strain in South Africa and spreading internationally …
(VoC) after becoming the dominant strain in South Africa and spreading internationally …
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B. 1.351) among persons identified through contact tracing in Israel: A …
SR Singer, FJ Angulo, DL Swerdlow… - …, 2021 - europepmc.org
Background SARS-CoV-2 variant Beta (B. 1.351) was designated as a Variant of Concern
(VoC) after becoming the dominant strain in South Africa and spreading internationally …
(VoC) after becoming the dominant strain in South Africa and spreading internationally …
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B. 1.351) among persons identified through contact tracing in Israel: A …
SR Singer, FJ Angulo, DL Swerdlow… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background SARS-CoV-2 variant Beta (B. 1.351) was designated as a Variant of Concern
(VoC) after becoming the dominant strain in South Africa and spreading internationally …
(VoC) after becoming the dominant strain in South Africa and spreading internationally …
Effectiveness of BNT162B2 mRNA COVID-19 vaccine against SARS-CoV-2 variant beta (B. 1.351) among persons identified through contact tracing in Israel: a …
SR Singer, FJ Angulo, DL Swerdlow, JM McLaughlin… - 2021 - cabidigitallibrary.org
Abstract Background: SARS-CoV-2 variant Beta (B. 1.351) was designated as a Variant of
Concern (VoC) after becoming the dominant strain in South Africa and spreading …
Concern (VoC) after becoming the dominant strain in South Africa and spreading …
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B. 1.351) among persons identified through contact tracing in Israel: A …
SR Singer, FJ Angulo, DL Swerdlow… - …, 2021 - europepmc.org
Background SARS-CoV-2 variant Beta (B. 1.351) was designated as a Variant of Concern
(VoC) after becoming the dominant strain in South Africa and spreading internationally …
(VoC) after becoming the dominant strain in South Africa and spreading internationally …